BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29754553)

  • 1. Strategies for integrating personalized medicine into healthcare practice.
    Pritchard DE; Moeckel F; Villa MS; Housman LT; McCarty CA; McLeod HL
    Per Med; 2017 Mar; 14(2):141-152. PubMed ID: 29754553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenging integration: clinicians' perspectives of communicating collaboration in a center for integrative medicine.
    Geist-Martin P; Bollinger BJ; Wiechert KN; Plump B; Sharf BF
    Health Commun; 2016; 31(5):544-56. PubMed ID: 26422797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative medicine and patient-centered care.
    Maizes V; Rakel D; Niemiec C
    Explore (NY); 2009; 5(5):277-89. PubMed ID: 19733814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
    Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
    Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
    Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
    Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of traditional Chinese medicine and Western medicine in the era of precision medicine.
    Wang WJ; Zhang T
    J Integr Med; 2017 Jan; 15(1):1-7. PubMed ID: 28088253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European healthcare systems readiness to shift from 'one-size fits all' to personalized medicine.
    Schee Genannt Halfmann S; Evangelatos N; Schröder-Bäck P; Brand A
    Per Med; 2017 Jan; 14(1):63-74. PubMed ID: 29749826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating research into clinical practice: making change happen.
    Bradley EH; Schlesinger M; Webster TR; Baker D; Inouye SK
    J Am Geriatr Soc; 2004 Nov; 52(11):1875-82. PubMed ID: 15507065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Personalized Medicine Coalition: goals and strategies.
    Abrahams E; Ginsburg GS; Silver M
    Am J Pharmacogenomics; 2005; 5(6):345-55. PubMed ID: 16336000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic-based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system.
    Subasri M; Barrett D; Sibalija J; Bitacola L; Kim RB
    Clin Transl Sci; 2021 Nov; 14(6):2231-2241. PubMed ID: 34080317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers for integrating personalized medicine into clinical practice: a qualitative analysis.
    Najafzadeh M; Davis JC; Joshi P; Marra C
    Am J Med Genet A; 2013 Apr; 161A(4):758-63. PubMed ID: 23444119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating China in the International Consortium for Personalised Medicine: a position paper on innovation and digitalization in Personalized Medicine.
    Beccia F; Di Marcantonio M; Causio FA; Schleicher L; Wang L; Cadeddu C; Ricciardi W; Boccia S
    BMC Public Health; 2024 Feb; 24(1):464. PubMed ID: 38355452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine. Closing the gap between knowledge and clinical practice.
    Anaya JM; Duarte-Rey C; Sarmiento-Monroy JC; Bardey D; Castiblanco J; Rojas-Villarraga A
    Autoimmun Rev; 2016 Aug; 15(8):833-42. PubMed ID: 27302209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and health economic challenges of personalized medicine].
    Brüggenjürgen B; Kornbluth L; Ferrara JV; Willich SN
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):710-4. PubMed ID: 22526860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International consortium for personalized medicine: an international survey about the future of personalized medicine.
    Venne J; Busshoff U; Poschadel S; Menschel R; Evangelatos N; Vysyaraju K; Brand A
    Per Med; 2020 Mar; 17(2):89-100. PubMed ID: 32154758
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethical concerns caused by integrative patient empowerment solutions for personalized medicine.
    Kuchinke W
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():4775-8. PubMed ID: 24110802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborating with medicine? Perceptions of Australian naturopaths on integrating within the conventional medical system.
    Wardle J; Steel A; Lauche R; Adams J
    J Interprof Care; 2017 Nov; 31(6):734-743. PubMed ID: 28876144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current landscape of personalized medicine adoption and implementation in Southeast Asia.
    Chong HY; Allotey PA; Chaiyakunapruk N
    BMC Med Genomics; 2018 Oct; 11(1):94. PubMed ID: 30367635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating China in the International Consortium for Personalized Medicine: A Position Paper on Personalized Medicine in Sustainable Healthcare.
    Causio FA; Beccia F; Hoxhaj I; Huang HY; Wang L; Wang W; Farina S; Osti T; Savoia C; Cadeddu C; Ricciardi W; Boccia S
    Public Health Genomics; 2024; 27(1):1-11. PubMed ID: 38061342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.